The Japan Times - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.276798
AFN 76.973093
ALL 96.541337
AMD 443.660189
ANG 2.0846
AOA 1067.888653
ARS 1669.958677
AUD 1.752514
AWG 2.096182
AZN 1.984351
BAM 1.955625
BBD 2.34549
BDT 142.477215
BGN 1.956439
BHD 0.438161
BIF 3440.791247
BMD 1.164546
BND 1.508565
BOB 8.047278
BRL 6.334667
BSD 1.164496
BTN 104.702605
BWP 15.471612
BYN 3.348
BYR 22825.091832
BZD 2.34209
CAD 1.610159
CDF 2599.265981
CHF 0.936209
CLF 0.027366
CLP 1073.571668
CNY 8.233458
CNH 8.232219
COP 4424.302993
CRC 568.848955
CUC 1.164546
CUP 30.860456
CVE 110.255106
CZK 24.203336
DJF 207.371392
DKK 7.470448
DOP 74.533312
DZD 151.068444
EGP 55.295038
ERN 17.468183
ETB 180.629892
FJD 2.632397
FKP 0.873977
GBP 0.872678
GEL 3.138497
GGP 0.873977
GHS 13.246811
GIP 0.873977
GMD 85.012236
GNF 10119.091982
GTQ 8.9202
GYD 243.638138
HKD 9.065875
HNL 30.671248
HRK 7.535429
HTG 152.446321
HUF 381.994667
IDR 19435.740377
ILS 3.768132
IMP 0.873977
INR 104.760771
IQD 1525.563106
IRR 49041.926882
ISK 149.038983
JEP 0.873977
JMD 186.393274
JOD 0.825709
JPY 180.924237
KES 150.636483
KGS 101.839952
KHR 4662.581612
KMF 491.43861
KPW 1048.137083
KRW 1716.311573
KWD 0.357481
KYD 0.970513
KZT 588.927154
LAK 25252.733992
LBP 104283.942272
LKR 359.197768
LRD 204.961608
LSL 19.736529
LTL 3.438601
LVL 0.704422
LYD 6.330432
MAD 10.755735
MDL 19.814222
MGA 5194.533878
MKD 61.634469
MMK 2445.172268
MNT 4132.506664
MOP 9.338362
MRU 46.438833
MUR 53.651052
MVR 17.938355
MWK 2019.3188
MXN 21.165153
MYR 4.787492
MZN 74.426542
NAD 19.736529
NGN 1688.68458
NIO 42.856154
NOK 11.767853
NPR 167.523968
NZD 2.015483
OMR 0.44694
PAB 1.164595
PEN 3.914449
PGK 4.941557
PHP 68.66747
PKR 326.476804
PLN 4.229804
PYG 8009.281302
QAR 4.244719
RON 5.092096
RSD 117.389466
RUB 89.441974
RWF 1694.347961
SAR 4.370508
SBD 9.584899
SCR 15.747587
SDG 700.4784
SEK 10.946786
SGD 1.508673
SHP 0.873711
SLE 27.603998
SLL 24419.93473
SOS 664.340387
SRD 44.985272
STD 24103.740676
STN 24.497802
SVC 10.190086
SYP 12876.900539
SZL 19.72123
THB 37.119932
TJS 10.684641
TMT 4.087555
TND 3.416093
TOP 2.803946
TRY 49.523506
TTD 7.894292
TWD 36.437508
TZS 2841.64501
UAH 48.888813
UGX 4119.630333
USD 1.164546
UYU 45.545913
UZS 13931.74986
VES 296.437311
VND 30697.419423
VUV 142.156724
WST 3.247609
XAF 655.898144
XAG 0.019964
XAU 0.000277
XCD 3.147243
XCG 2.098812
XDR 0.815727
XOF 655.898144
XPF 119.331742
YER 277.802752
ZAR 19.711451
ZMK 10482.311144
ZMW 26.923584
ZWL 374.983176
  • RBGPF

    0.0000

    78.35

    0%

  • CMSD

    -0.0700

    23.25

    -0.3%

  • NGG

    -0.5000

    75.41

    -0.66%

  • SCS

    -0.0900

    16.14

    -0.56%

  • AZN

    0.1500

    90.18

    +0.17%

  • RELX

    -0.2200

    40.32

    -0.55%

  • BTI

    -1.0300

    57.01

    -1.81%

  • RYCEF

    -0.0500

    14.62

    -0.34%

  • CMSC

    -0.0500

    23.43

    -0.21%

  • GSK

    -0.1600

    48.41

    -0.33%

  • BCC

    -1.2100

    73.05

    -1.66%

  • BCE

    0.3300

    23.55

    +1.4%

  • JRI

    0.0400

    13.79

    +0.29%

  • VOD

    -0.1630

    12.47

    -1.31%

  • BP

    -1.4000

    35.83

    -3.91%

  • RIO

    -0.6700

    73.06

    -0.92%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

K.Okada--JT